The U.S. Food and Drug Administration (FDA), working with Med Prep Consulting Inc., announced a nationwide recall of drugs made by a New Jersey compounding pharmacy due to a possible mold contamination.
To date, there have been no reports of illness associated with the recalled drugs. The agency is working with the company to assess the scope of contamination.
The recalled drugs include several dozen pain relievers, antibiotics and drugs that are used during labor and surgery. They were distributed to hospitals in Connecticut, Delaware, New Jersey and Pennsylvania.
Med Prep, a compounding pharmacy, mixes custom formulations of drugs made to meet doctors’ specifications. This is the second recall in less than a year due to contamination.
The FDA, in recent weeks, has been more aggressive about inspecting compounding pharmacies in many states.
All production and shipping has been halted as of Friday after the company and The New Jersey State Board of Pharmacy reached an agreement.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.